House Bill No. [insert bill number] amends R.S. 22:1076.1 to revise the composition and operational procedures of the advisory board for rare cancer treatments in Louisiana. The bill increases the number of board members from fifteen to seventeen and replaces the executive director of "Taking Aim at Cancer in Louisiana" with the executive director of the "Cancer Association of Louisiana." Additionally, the number of oncologists specializing in rare cancers on the board is increased from two to four.

The bill also stipulates that the advisory board will hold quarterly public meetings and requires that a formal written report of findings be submitted to the House Committee on Insurance and the Senate Committee on Insurance no later than forty-five days after each meeting. The commissioner is granted the authority to promulgate necessary administrative rules and regulations to implement these provisions. The act will take effect upon the governor's signature or, if not signed, after the designated period for bills to become law without signature.

Statutes affected:
HB761 Original:
HB761 Engrossed:
HB761 Reengrossed:
HB761 Enrolled: